Cardinal Point Capital

VMG Partners is a San Francisco-based investment firm dedicated to elevating entrepreneurs who are transforming the consumer experience through innovative brands and technologies. With nearly twenty years of experience, VMG combines financial and human capital to support visionary companies in navigating dynamic market conditions and achieving their bold aspirations. Focused on fostering diversity and inclusion, VMG launched the Parity Collective initiative to support founders from historically underserved backgrounds. The firm prides itself on its unique, progressive culture, providing hands-on partnership and expertise to help entrepreneurs realize their potential and drive significant results. Generated from the website

Welcome to Passport CapitalPassport Capital LLC is a San Francisco based, global investment firm founded by John H. Burbank III in 2000. The firm manages approximately $4.4 billion in assets. Passport's investment process uses a combination of macroeconomic analyses to develop major themes and rigorous fundamental research on individual companies to create global portfolios. The firm's investment team focuses on the following areas: Agriculture, Basic Materials, Consumer, Energy, Financial Services, Healthcare, Capital Markets, Internet / Technology, India and Middle East & North Africa. As appropriate, the firm makes available to its investors co-investment opportunities.Passport Capital is a federally registered investment advisor with the United States Securities and Exchange Commission.

Copernicus Capital Management, based in San Francisco, excels in investing within the biotechnology and healthcare sectors, capitalizing on the growing demand for innovative solutions driven by an aging population and advancements in medical technology. Their disciplined investment strategy focuses on identifying transformative therapies while managing risk through a concentrated public and private equity portfolio. Founded by John W. Rende in 2013, the firm combines a strong culture of integrity with intellectual rigor to generate superior returns for investors. With a proven track record spanning various roles in the healthcare and investment fields, Rende leverages his extensive experience to guide Copernicus in navigating the complexities of the biotechnology landscape. Generated from the website